Combination of eplerenone and an hmg coa reductase inhibitor

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 45/06 (2006.01) A61K 31/22 (2006.01) A61K 31/365 (2006.01) A61K 31/40 (2006.01) A61K 31/44 (2006.01) A61K 31/4747 (2006.01) A61K 31/585 (2006.01)

Patent

CA 2452678

Novel methods and combinations for the treatment and/or prophylaxis of a pathologic condition in a subject, wherein the methods comprise the administration of one or more HMG Co-A reductase inhibitors and one or more aldosterone receptor antagonists, and the combinations comprise one or more HMG Co-A reductase inhibitors and one or more of said aldosterone receptor antagonists.

L'invention concerne des nouveaux procédés et de nouvelles combinaisons destinés au traitement et/ou à la prophylaxie d'une condition pathologique chez un sujet. Ce procédé comprend l'administration de un ou plusieurs inhibiteurs de réductase d'HMG Co-A et de un ou plusieurs antagonistes de récepteur d'aldostérone. Ces combinaisons comportent un ou plusieurs inhibiteurs de réductase HMG Co-A et un ou plusieurs antagonistes de récepteur d'aldostérone.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of eplerenone and an hmg coa reductase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of eplerenone and an hmg coa reductase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of eplerenone and an hmg coa reductase inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1546869

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.